A fast-growing K-Beauty brand — call it Brand A — recently appeared in not one but two FDA public databases. First in CAERS, the FDA's cosmetics adverse event reporting system. Then in MAUDE, the medical device adverse event database. No recall. No import alert. But showing up across two separate FDA systems at the same time? That kind of thing gets noticed. Why an FDA Database Listing Is Never Just a Footnote CAERS and MAUDE are fully public. No login required. Any consumer,

K-Beauty Sunscreens: Beloved by U.S. Consumers, Challenged by Tariffs and FDA Rules K-Beauty sunscreens are among the most popular Korean...

November 6, 2024 In an industry as competitive and fast-evolving as cosmetics, staying compliant with FDA regulations isn’t just...

November 4, 2024 Introduction As K-beauty brands continue to gain popularity in the U.S., navigating FDA regulations is crucial for...

October 04, 2024 K-beauty has made waves globally with its innovative formulations, vibrant packaging, and promises of healthy, glowing...

October 03, 2024 The K-beauty industry has rapidly expanded its reach, captivating U.S. consumers with innovative skincare products and...

October 02, 2024 K-beauty is renowned for its use of innovative and unique ingredients like snail mucin, ginseng, and centella asiatica,...